“…Particularly, by acting as antioxidant, anti-mutagen as well as by inducing phase II drug-metabolizing enzymes, trans-resveratrol inhibits the initiation phase of tumorigenesis; concomitantly, it mediates the anti-inflammatory response and induces cell differentiation, thereby inhibiting tumor promotion and progression, respectively [28]. Subsequently, other groups reported the anti-proliferative and pro-apoptotic activity of trans-resveratrol in several tumor cell lines [2,27,41,56], suggesting that it can function by modulating and interacting with a broad range of cellular targets, ranging from cell surface receptors [5,7] to caspases [43]; from mitochondria [8] and mitochondria-associated proteins [43,50,60], to intracellular protein kinases, such as protein kinase B (PKB)/Akt, PKC, MAP kinases [34,57,58,62,65] and transcription factors (e.g. p53, pRb, c-Jun and NF-jB) [30,37,45,59].…”